MicroRNA in pancreatic cancer: Pathological, diagnostic and therapeutic implications

Cancer Letters

Volumn 292, Issue 1, 2010, Pages 8-16

  Rachagani, Satyanarayana ^a   Kumar, Sushil ^a   Batra, Surinder K ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Diagnosis and therapy; MicroRNA; Pancreatic cancer

Indexed keywords

3,3' DIINDOLYLMETHANE; 5 AZA 2' DEOXYCYTIDINE; ANTISENSE OLIGONUCLEOTIDE; CURCUMIN; GEMCITABINE; ISOFLAVONE; MICRORNA; PROTEIN P53; TRICHOSTATIN A; TUMOR MARKER;

CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE ARREST; CHRONIC PANCREATITIS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION PROFILING; HUMAN; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PRIORITY JOURNAL; PROGNOSIS; RNA SYNTHESIS; SHORT SURVEY; TUMOR GROWTH; BIOSYNTHESIS; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; PANCREAS TUMOR; PHYSIOLOGY; PROTEIN FOLDING; REVIEW; TUMOR CELL LINE;

MAMMALIA;

CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; PANCREATIC NEOPLASMS; PROGNOSIS; PROTEIN FOLDING; TUMOR MARKERS, BIOLOGICAL;

EID: 77951223405     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.11.010     Document Type: Review

References (123)

1. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS. Med. 2006, 3:442.
2. Saif M.W. Pancreatic cancer: highlights from the 42nd annual meeting of the American Society of Clinical Oncology 2006. JOP 2006, 7:337-348.
3. Jemal A., Siegel R., Ward E., Murray T., Xu J., Thun M.J. Cancer statistics. CA Cancer J. Clin. 2007, 57:43-66.
4. Warshaw A.L., Fernandez-del C.C. Pancreatic carcinoma. New. Engl. J. Med. 1992, 326:455-465.
5. Niederhuber J.E., Brennan M.F., Menck H.R. The National Cancer Data Base report on pancreatic cancer. Cancer 1995, 76:1671-1677.
6. Lu J., Getz G., Miska E.A., Varez-Saavedra E., Lamb J., Peck D., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
7. He H., Jazdzewski K., Li W., Liyanarachchi S., Nagy R., Volinia S., et al. The role of microRNA genes in papillary thyroid carcinoma. Proc. Natl. Acad. Sci. USA 2005, 102:19075-19080.
8. Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005, 65:7065-7070.
9. Murakami Y., Yasuda T., Saigo K., Urashima T., Toyoda H., Okanoue T., et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006, 25:2537-2545.
10. Roldo C., Missiaglia E., Hagan J.P., Falconi M., Capelli P., Bersani S., et al. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J. Clin. Oncol. 2006, 24:4677-4684.
11. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 2006, 103:2257-2261.
12. Yanaihara N., Caplen N., Bowman E., Seike M., Kumamoto K., Yi M., et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006, 9:189-198.
13. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
14. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
15. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
16. Pasquinelli A.E., Reinhart B.J., Slack F., Martindale M.Q., Kuroda M.I., Maller B., et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000, 408:86-89.
17. Chen C.Z., Li L., Lodish H.F., Bartel D.P. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004, 303:83-86.
18. Chen J.F., Mandel E.M., Thomson J.M., Wu Q., Callis T.E., Hammond S.M., et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Natl. Genet. 2006, 38:228-233.
19. Zhao Y., Samal E., Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 2005, 436:214-220.
20. Bentwich I., Avniel A., Karov Y., Aharonov R., Gilad S., Barad O., et al. Identification of hundreds of conserved and nonconserved human microRNAs. Natl. Genet. 2005, 37:766-770.
21. Carthew R.W. Gene regulation by microRNAs. Curr. Opin. Genet. Dev. 2006, 16:203-208.
22. Rodriguez A., Griffiths-Jones S., Ashurst J.L., Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res. 2004, 14:1902-1910.
23. Zeng Y. Principles of micro-RNA production and maturation. Oncogene 2006, 25:6156-6162.
24. Cai X., Hagedorn C.H., Cullen B.R. Human microRNAs are processed from capped polyadenylated transcripts that can also function as mRNAs. RNA 2004, 10:1957-1966.
25. Lagos-Quintana M., Rauhut R., Lendeckel W., Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001, 294:853-858.
26. Lau N.C., Lim L.P., Weinstein E.G., Bartel D.P. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001, 294:858-862.
27. Lee R.C., Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001, 294:862-864.
28. Lee Y., Jeon K., Lee J.T., Kim S., Kim V.N. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 2002, 21:4663-4670.
29. Hayashita Y., Osada H., Tatematsu Y., Yamada H., Yanagisawa K., Tomida S., et al. miR-17-92 is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 2005, 65:9628-9632.
30. Lin S.L., Ying S.Y. Gene silencing in vitro and in vivo using intronic microRNAs. Methods Mol. Biol. 2006, 342:295-312.
31. Lin S.L., Miller J.D., Ying S.Y. Intronic MicroRNA (miRNA). J. Biomed. Biotechnol. 2006, 2006:26818.
32. Kim V.N. MicroRNA biogenesis: coordinated cropping and dicing. Natl. Rev. Mol. Cell Biol. 2005, 6:376-385.
33. Lee Y., Kim M., Han J., Yeom K.H., Lee S., Baek S.H., et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004, 23:4051-4060.
34. Gregory R.I., Yan K.P., Amuthan G., Chendrimada T., Doratotaj B., Cooch N., et al. The Microprocessor complex mediates the genesis of microRNAs. Nature 2004, 432:235-240.
35. Denli A.M., Tops B.B., Plasterk R.H., Ketting R.F., Hannon G.J. Processing of primary microRNAs by the Microprocessor complex. Nature 2004, 432:231-235.
36. Gregory R.I., Shiekhattar R. MicroRNA biogenesis and cancer. Cancer Res. 2005, 65:3509-3512.
37. Han J., Lee Y., Yeom K.H., Nam J.W., Heo I., Rhee J.K., et al. Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell 2006, 125:887-901.
38. Landthaler M., Yalcin A., Tuschl T. The human DiGeorge syndrome critical region gene 8 and Its D. melanogaster homolog are required for miRNA biogenesis. Curr. Biol. 2004, 14:2162-2167.
39. Lee Y., Ahn C., Han J., Choi H., Kim J., Yim J., et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003, 425:415-419.
40. Bohnsack M.T., Czaplinski K., Gorlich D. Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA 2004, 10:185-191.
41. Lund E., Guttinger S., Calado A., Dahlberg J.E., Kutay U. Nuclear export of microRNA precursors. Science 2004, 303:95-98.
42. Yi R., Qin Y., Macara I.G., Cullen B.R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 2003, 17:3011-3016.
43. Chendrimada T.P., Gregory R.I., Kumaraswamy E., Norman J., Cooch N., Nishikura K., et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005, 436:740-744.
44. Gregory R.I., Chendrimada T.P., Cooch N., Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 2005, 123:631-640.
45. Jiang F., Ye X., Liu X., Fincher L., McKearin D., Liu Q. Dicer-1 and R3D1-L catalyze microRNA maturation in Drosophila. Genes Dev. 2005, 19:1674-1679.
46. Meister G., Landthaler M., Dorsett Y., Tuschl T. Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 2004, 10:544-550.
47. Saito K., Ishizuka A., Siomi H., Siomi M.C. Processing of pre-microRNAs by the Dicer-1-Loquacious complex in Drosophila cells. PLoS. Biol. 2005, 3:e235.
48. Forstemann K., Tomari Y., Du T., Vagin V.V., Denli A.M., Bratu D.P., et al. a double-stranded RNA-binding domain protein. PLoS. Biol. 2005, 3:e236.
49. Bernstein E., Kim S.Y., Carmell M.A., Murchison E.P., Alcorn H., Li M.Z., et al. Dicer is essential for mouse development. Natl. Genet. 2003, 35:215-217.
50. Hammond S.M., Bernstein E., Beach D., Hannon G.J. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 2000, 404:293-296.
51. Khvorova A., Reynolds A., Jayasena S.D. Functional siRNAs and miRNAs exhibit strand bias. Cell 2003, 115:209-216.
52. Hutvagner G., Zamore P.D. A microRNA in a multiple-turnover RNAi enzyme complex. Science 2002, 297:2056-2060.
53. Brennecke J., Stark A., Russell R.B., Cohen S.M. Principles of microRNA-target recognition. PLoS. Biol. 2005, 3:e85.
54. Doench J.G., Sharp P.A. Specificity of microRNA target selection in translational repression. Genes Dev. 2004, 18:504-511.
55. Lai E.C. Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation. Natl. Genet. 2002, 30:363-364.
56. He L., Hannon G.J. MicroRNAs: small RNAs with a big role in gene regulation. Natl. Rev. Genet. 2004, 5:522-531.
57. Kiriakidou M., Nelson P.T., Kouranov A., Fitziev P., Bouyioukos C., Mourelatos Z., et al. A combined computational-experimental approach predicts human microRNA targets. Genes Dev. 2004, 18:1165-1178.
58. Krek A., Grun D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., et al. Combinatorial microRNA target predictions. Natl. Genet. 2005, 37:495-500.
59. Lewis B.P., Shih I.H., Jones-Rhoades M.W., Bartel D.P., Burge C.B. Prediction of mammalian microRNA targets. Cell 2003, 115:787-798.
60. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
61. Caldas C., Brenton J.D. Sizing up miRNAs as cancer genes. Natl. Med. 2005, 11:712-714.
62. Chan J.A., Krichevsky A.M., Kosik K.S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005, 65:6029-6033.
63. Cimmino A., Calin G.A., Fabbri M., Iorio M.V., Ferracin M., Shimizu M., et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. USA 2005, 102:13944-13949.
64. Croce C.M., Calin G.A. miRNAs, cancer, and stem cell division. Cell 2005, 122:6-7.
65. Esquela-Kerscher A., Slack F.J. Oncomirs - microRNAs with a role in cancer. Natl. Rev. Cancer. 2006, 6:259-269.
66. Johnson S.M., Grosshans H., Shingara J., Byrom M., Jarvis R., Cheng A., et al. RAS is regulated by the let-7 microRNA family. Cell 2005, 120:635-647.
67. McManus M.T. MicroRNAs and cancer. Semin. Cancer Biol. 2003, 13:253-258.
68. Meltzer P.S. Cancer genomics: small RNAs with big impacts. Nature 2005, 435:745-746.
69. Sevignani C., Calin G.A., Siracusa L.D., Croce C.M. Mammalian microRNAs: a small world for fine-tuning gene expression. Mamm. Genome 2006, 17:189-202.
70. Sempere L.F., Freemantle S., Pitha-Rowe I., Moss E., Dmitrovsky E., Ambros V. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 2004, 5:R13.
71. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 2002, 99:15524-15529.
72. Calin G.A., Liu C.G., Sevignani C., Ferracin M., Felli N., Dumitru C.D., et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc. Natl. Acad. Sci. USA 2004, 101:11755-11760.
73. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA 2004, 101:2999-3004.
74. Agirre X., Jimenez-Velasco A., San Jose-Eneriz E., Garate L., Bandres E., Cordeu L., et al. Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth. Mol. Cancer Res. 2008, 6:1830-1840.
75. Eis P.S., Tam W., Sun L., Chadburn A., Li Z., Gomez M.F., et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. USA. 2005, 102:3627-3632.
76. Kluiver J., Poppema S., de J.D., Blokzijl T., Harms G., Jacobs S., et al. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J. Pathol. 2005, 207:243-249.
77. Metzler M., Wilda M., Busch K., Viehmann S., Borkhardt A. High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes. Cancer 2004, 39:167-169.
78. Michael M.Z., O' Connor S.M., van Holst Pellekaan N.G., Young G.P., James R.J. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res. 2003, 1:882-891.
79. Takamizawa J., Konishi H., Yanagisawa K., Tomida S., Osada H., Endoh H., et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004, 64:3753-3756.
80. Sun M., Estrov Z., Ji Y., Coombes K.R., Harris D.H., Kurzrock R. Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol. Cancer Ther. 2008, 7:464-473.
81. Babak T., Zhang W., Morris Q., Blencowe B.J., Hughes T.R. Probing microRNAs with microarrays: tissue specificity and functional inference. RNA 2004, 10:1813-1819.
82. Allawi H.T., Dahlberg J.E., Olson S., Lund E., Olson M., Ma W.P., et al. Quantitation of microRNAs using a modified Invader assay. RNA 2004, 10:1153-1161.
83. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Natl. Protoc. 2008, 3:1101-1108.
84. Jiang J., Lee E.J., Gusev Y., Schmittgen T.D. Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res. 2005, 33:5394-5403.
85. Bloomston M., Frankel W.L., Petrocca F., Volinia S., Alder H., Hagan J.P., et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007, 297:1901-1908.
86. Gironella M., Seux M., Xie M.J., Cano C., Tomasini R., Gommeaux J., et al. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc. Natl. Acad. Sci. USA 2007, 104:16170-16175.
87. Lee E.J., Gusev Y., Jiang J., Nuovo G.J., Lerner M.R., Frankel W.L., et al. Expression profiling identifies microRNA signature in pancreatic cancer. Int. J. Cancer. 2007, 120:1046-1054.
88. Szafranska A.E., Davison T.S., John J., Cannon T., Sipos B., Maghnouj A., et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 2007, 26:4442-4452.
89. Tsuda N., Ishiyama S., Li Y., Ioannides C.G., Abbruzzese J.L., Chang D.Z. Synthetic microRNA designed to target glioma-associated antigen 1 transcription factor inhibits division and induces late apoptosis in pancreatic tumor cells. Clin. Cancer Res. 2006, 12:6557-6564.
90. Poy M.N., Eliasson L., Krutzfeldt J., Kuwajima S., Ma X., Macdonald P.E., et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004, 432:226-230.
91. Olson P., Lu J., Zhang H., Shai A., Chun M.G., Wang Y., et al. MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer. Genes Dev. 2009, 23:2152-2165.
92. Zhang Y., Li M., Wang H., Fisher W.E., Lin P.H., Yao Q., et al. Profiling of 95 MicroRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J. Surg. 2008, 33:698-709.
93. Habbe N., Koorstra J.B., Mendell J.T., Offerhaus G.J., Ryu J.K., Feldmann G., et al. MicroRNA miR-155 is a biomarker of early pancreatic neoplasia. Cancer Biol. Ther. 2009, 8:340-346.
94. Baskerville S., Bartel D.P. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 2005, 11:241-247.
95. Sood P., Krek A., Zavolan M., Macino G., Rajewsky N. Cell-type-specific signatures of microRNAs on target mRNA expression. Proc. Natl. Acad. Sci. USA 2006, 103:2746-2751.
96. Gusev Y. Computational methods for analysis of cellular functions and pathways collectively targeted by differentially expressed microRNA. Methods 2008, 44:61-72.
97. Gusev Y., Schmittgen T.D., Lerner M., Postier R., Brackett D. Computational analysis of biological functions and pathways collectively targeted by co-expressed microRNAs in cancer. BMC Bioinformatics 2007, 8:S16.
98. O'Donnell K.A., Wentzel E.A., Zeller K.I., Dang C.V., Mendell J.T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005, 435:839-843.
99. Watanabe S., Ueda Y., Akaboshi S.I., Hino Y., Sekita Y., Nakao M. HMGA2 Maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cells. Am. J. Pathol. 2009, 174:854-868.
100. Chang T.C., Wentzel E.A., Kent O.A., Ramachandran K., Mullendore M., Lee K.H., et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell 2007, 26:745-752.
101. Lodygin D., Tarasov V., Epanchintsev A., Berking C., Knyazeva T., Korner H., et al. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 2008, 7:2591-2600.
102. Mendell J.T. miRiad roles for the miR-17-92 cluster in development and disease. Cell 2008, 133:217-222.
103. Ventura A., Young A.G., Winslow M.M., Lintault L., Meissner A., Erkeland S.J., et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 2008, 132:875-886.
104. Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Natl. Rev. Genet. 2009, 10:704-714.
105. Lee K.H., Lotterman C., Karikari C., Omura N., Feldmann G., Habbe N., et al. Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. Pancreatology 2009, 9:293-301.
106. Moriyama T., Ohuchida K., Mizumoto K., Yu J., Sato N., Nabae T., et al. MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Mol. Cancer Ther. 2009, 8:1067-1074.
107. Torrisani J., Bournet B., du Rieu M.C., Bouisson M., Souque A., Escourrou J., et al. Let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. Hum. Gene Ther. 2009, 20:831-844.
108. Burk U., Schubert J., Wellner U., Schmalhofer O., Vincan E., Spaderna S., et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 2008, 9:582-589.
109. Zhang S., Cai X., Huang F., Zhong W., Yu Z. Effect of trichostatin a on viability and microRNA expression in human pancreatic cancer cell line BxPC-3. Exp. Oncol. 2008, 30:265-268.
110. Li Y., VandenBoom T.G., Kong D., Wang Z., Ali S., Philip P.A., et al. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res. 2009, 69:6704-6712.
111. Calin G.A., Ferracin M., Cimmino A., Di L.G., Shimizu M., Wojcik S.E., et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. New Engl. J. Med. 2005, 353:1793-1801.
112. Ciafre S.A., Galardi S., Mangiola A., Ferracin M., Liu C.G., Sabatino G., et al. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem. Biophys. Res. Commun. 2005, 334:1351-1358.
113. Ota A., Tagawa H., Karnan S., Tsuzuki S., Karpas A., Kira S., et al. as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res. 2004, 64:3087-3095.
114. Zhu Z., Gao W., Qian Z., Miao Y. Genetic variation of miRNA sequence in pancreatic cancer. Acta Biochim. Biophys. Sin. (Shanghai). 2009, 41:407-413.
115. Dillhoff M., Liu J., Frankel W., Croce C., Bloomston M. MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J. Gastrointest. Surg. 2008, 12:2171-2176.
116. Szafranska A.E., Doleshal M., Edmunds H.S., Gordon S., Luttges J., Munding J.B., et al. Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues. Clin. Chem. 2008, 54:1716-1724.
117. Wang J., Chen J., Chang P., LeBlanc A., Li D., Abbruzzesse J.L., et al. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev. Res. (Phila Pa). 2009, 2:807-813.
118. Greither T., Grochola L.F., Udelnow A., Lautenschlager C., Wurl P., Taubert H. Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int. J. Cancer 2009, (Epub ahead of print).
119. Tsuda N., Mine T., Ioannides C.G., Chang D.Z. Synthetic microRNA targeting glioma-associated antigen-1 protein. Methods Mol. Biol. 2009, 435-449. (487:435-49).
120. Torrisani J., Bournet B., du Rieu M.C., Bouisson M., Souque A., Escourrou J., et al. Let-7 MicroRNA Transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. Hum. Gene Ther. 2009, 20:831-844.
121. Park J.K., Lee E.J., Esau C., Schmittgen T.D. Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma. Pancreas 2009, 1:1. (Epub ahead of print).
122. Weiss F.U., Marques I.J., Woltering J.M., Vlecken D.H., Aghdassi A., Partecke L.I., et al. Retinoic acid receptor (RAR) antagonists inhibit miR-10a expression and block metastatic behaviour of pancreatic cancer. Gastroenterology 2009, (Epub ahead of print).
123. Ji Q., Hao X., Zhang M., Tang W., Yang M., Li L., et al. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS. One 2009, 4:e6816.